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Abstract: 
This article presents a case of a 17-year old girl with primary antiphospholipid syndrome 
developing subacute signs of hand and leg ischaemia caused by radiologically verified radial and 
popliteal artery occlusion. She is successfully treated with a thrombolytic agent (alteplase) and 
recovers completely. Her laboratory results came positive for all three subtypes of 
antiphospholipid antibodies. This kind of antiphospholipid syndrome presentation is a very rare 
entity in itself. Shortly afterwards her mother is diagnosed with primary antiphospholipid 
syndrome as well. A familial form of antiphospholipid syndrome is suspected. Combination of a 
familial antiphospholipid syndrome presenting as bivessel arterial thrombosis is a unique case, to 
the best of our knowledge, never described in the literature before. 
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Introduction: 
Antiphospholipid syndrome (APS) is an autoimmune multisystem prothrombotic 
disorder which by definition presents itself with thromboembolic events and 
positive laboratory tests for antiphospholipid (aPL) antibodies [1]. There is a 
whole panel of aPL antibodies, but only three types are included in the diagnostic 
criteria and are standardized worldwide. These are antibodies against cardiolipin 
(aCL), β2-glycoprotein I (β2-GPI) and the lupus anticoagulant (LAC) [2]. 
Antiphospholipid syndrome is also known as the Hughes syndrome and is usually 
divided into three groups: the primary APS, APS associated with systemic lupus 
erythematosus (SLE) or some other lupus-like connective tissue disorder 
(formerly known as the secondary APS) and the so-called catastrophic 
antiphospholipid syndrome (CAPS), a rare form of APS which leeds to 
disseminated intravascular coagulation causing rapid death [3]. For the adult 
population, there are international diagnostic criteria which were last time revised 
in 2007 [2]. They include at least one clinical thrombotic manifestation and at 
least one persistently positive aPL antibody (positive on two or more occasions at 
least 12 weeks apart). Clinical guidelines for adult APS include obstetric problems 
as well, most commonly recurrent miscarriages [2]. Internationally standardized 
classification and guidelines had not yet been made for the paediatric population. 
When diagnosing APS in a child, one is left only with modified adult criteria. 
Nevertheless, the majority of APS characteristics are the same [4]. 
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Case presentation: 
We present a 17-year old Caucasian who is transferred mid- December 2009 to 
our hospital with signs of subacute limb ischaemia and a sonographically raised 
suspicion of a left popliteal and right radial artery occlusion. Her symptoms began 
mid-November with itchiness and rash of the little finger of the right hand and 
then with pain, cyanosis and paresthesia of her left toe, progressing to the whole 
left lower leg. Because of irregular menstrual cycles, she had been using oral 
contraceptives (Logest – composed of gestoden and ethinylestradiol) for three 
months up to the moment presented symptoms occured. First, she was admitted to 
a local hospital under the suspicion of acute limb ischaemia. Right radial artery 
and left popliteal artery occlusion were sonographically verified and the girl was 
started on low molecular weight heparine (LWMH) – Clivarine and stopped using 
oral contraceptives. A partial improvement was noted. 
Then she was referred to our Department for further therapeutic and diagnostic 
procedures considering APS or vasculitis as the underlying disorder. On 
admission, she reported pain in the left popliteal fossa. Her right radial pulse was 
feable and arteries distal to the common femoral artery on the left leg couldn't be 
palpated. A non-specific non-blanching rash was noted on her right hand. Her 
laboratory results showed slightly elevated d-dimers, slight thrombocytopenia and 
anaemia. Other than that, her blood tests and complete metabolic panel didn't 
show any significant pathologic findings. Her prothrombotic test panel came 
positive for LAC and showed elevated titers of aCL (both IgG and IgM) and 
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particularly anti β2-GPI. Other results for coagulation disorders came back 
negative (FV mutation, FII mutation,PAI mutation, protein S, protein C, F VIII, F 
IX, F X activity). 
Day after admission, here limb ischaemia symptoms reoccured. An urgent digital 
subtraction angiogram (DSA) was performed with concurrent alteplase 
thrombolytic therapy being conducted (Fig.1 Angiogram showing occlusion of the 
popliteal artery prior to the thrombolytic therapy, the distance x1 indicating the 
length of the arterial occlusion). Shortly after the thrombolytic therapy, her 
symptoms subsided and the control angiogram showed significant improvement, 
although initially, there persisted some patency problems (Fig.2 Angiogram 
performed six hours after the thrombolysis, still showing some patency problems 
of the popliteal artery). The same were absent on the subsequent angiograms 
(Fig.3 Angiogram performed 42 hours after thrombolysis showing completely 
patent popliteal artery). Other than that, she was started on parenteral 
anticoagulation therapy until the sonographic findings, pletysmographic pulse - 
waves and ankle-brachial index didn't normalize completely. 
End of December 2009, she was released from the hospital, completely recovered 
and with reccomendation of warfarin therapy. Repeated testing, performed more 
than 12 weeks later, showed persistently elevated aPL antibodies and persistently 
negative ANA, thereby confirming the diagnosis of primary antiphospholipid 
syndrome. 
The mother of the girl was diagnosed with primary APS just months afterwards. 
She presented with simptoms of superficial thrombophlebitis and her blood tests 
showed elevated aCL, LAC and β2-GPI on more than two occasions. She is 
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currently under surveillance for a possible progression into a secondary APS 
connected with SLE, considering her history of arthritides, dermatologic problems 
(livedo reticularis and exanthematous eruptions) and laboratory results showing 
slight leukopenia and persistently lowered whole complement activity. Her HLA 
typisation showed following genotype – HLA A 11/28, B 35/39, DR 11/16. 
Beside the forementioned, the girl's family history includes father dying from 
consequences of a heart attack at the age of 45 years.  
During subsequent follow-up, both the mother and the daughter remain positive 
for aCL antibodies and continue receiving oral anticoagulant therapy (warfarin). 
 
Discussion: 
We report a case of a 17-year old girl who presents with subacute hand and leg 
ischaemia. Soon after, radiological work-up reveals left popliteal artery and right 
radial artery occlusion which are successfully treated with thrombolytic – 
alteplase therapy. The girl's laboratory tests showed positive LAC and elevated 
aCL and anti – β2-GPI, which, together with clinical findings fulfill criteria for 
APS diagnosis. She hasn't got any acquired prothrombotic risk factors except for a 
three-month history of oral contraceptive taking due to irregular menstrual cycles. 
Paediatric APS extremely rarely presents with acute limb ischaemia. Our 
literature review came up with only one report of acute distal ischaemia as a 
presentation of antiphospholipid syndrome in a child [5], [6]. 
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Additionally, the possibility of a familial APS makes this case report even more 
interesting, since it's not a common clinical entity. Namely, her mother developed 
thromboses and has elevated serum aPL-antibodies, and her father died of a 
myocardial infarction at the early age of 45. Mother is currently diagnosed with 
primary APS and is under futher monitoring in case she develops a connective 
tissue disorder. 
Familial clusterings of raised levels of aPL antibodies have been described, but 
the reports are heterogeneous with regard to the characterization of the APS, 
coexisting autoimmune diseases and clinical complications [7]. Altogether, there 
are few cases in the literature describing siblings or a parent and a child having 
both elevated aPL levels and thrombotic manifestations. And even in these cases 
it is hard to conclude the exact role of aPL antibodies since there is either an 
autommune disease or some other hereditary prothrombotic feature involved as 
well. 
There have been conducted statistical analyses on families with APS clusterings, 
and these have shown a possible autosomal dominant pattern of inheritance of 
aPL antibody production and associated clinical manifestations [8]. Still, no firm 
gene association has been identified for APS yet, in part because of the rarity of 
multiplex families to study and because of the possibility of another familial cause 
of thrombotic disease [9]. 
Other genetic analyses have shown certain HLA types linked to a higher 
frequency of positive aPL-antibodies. These are HLA-DR4, -DR7, -DRw53 and -
DQB1*0302 , the same association pattern being found in patients with primary 
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APS and in those who are aPL positive connected with SLE or some other 
connective tissue disease.  
Another representative antigen, β2-glycoprotein-I (β2-GPI), expresses a 
valine(247)/leucine polymorphism which could be another genetic risk for 
presenting anti-β2-GPI antibodies and APS [10], [11]. 
Everything considered, mechanisms and pathophysiology of thrombosis in APS 
are highly heterogeneous and multifactorial, and that's why different genes and 
acquired factors seem to be involved  [10], [7]. 
 
Conclusion :  
Antiphospholipid syndrome usually presents with venous thromboses, especially 
deep venous thrombosis (DVT) of the lower extremities. APS presenting as 
arterial occclusion, especially one occuring at two sites at once is a very rare 
finding [11]. Additionally, familial clustering of primary APS is not common 
either. The genetic foundation of familial APS is a complex issue still being 
investigated and that's why this kind of reports are especially valuable in shedding  
light on it.  
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Figure legends: 
 
Fig. 1: Digital subtraction angiogram showing almost complete left popliteal artery occlusion 
measuring 5 cm in length. This figure depicts arterial patency prior to thrombolytic therapy.  
 
Fig. 2: Angiogram showing popliteal artery patency six hours after intravenous alteplase 
application. 
 
Fig. 3: Angiogram showing a completely patent popliteal artery, 42 hours after succefully 
conducted thrombolytic therapy. 
 
 
